Evidence map›Paper›PMID 39165174›Full record

ArticleAnalytical chemistry2024

Deciphering the Evolution of Inertial Migration in Serpentine Channels.

Yong Liu, Jun Zhang, Xiaobo Peng, Sheng Yan

Abstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yong LiuInstitute for Advanced Study, Shenzhen University, Shenzhen 518060, China.
Jun ZhangQueensland Micro- and Nanotechnology Centre, Nathan, Queensland 4111, Australia.ORCID 0000-0003-1113-6264
Xiaobo PengCollege of Mechatronics and Control Engineering, Shenzhen University, Shenzhen 518060, China.
Sheng YanInstitute for Advanced Study, Shenzhen University, Shenzhen 518060, China.ORCID 0000-0002-3463-0786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serpentine channels coupling inertial and secondary flows enable effective particle focusing and separation, showing great potential in clinical diagnostics and drug screening. However, the nonsteady secondary flows in the serpentine channel make the evolution of inertial migration unclear, hindering the development and application of the serpentine channel. Herein, to refine the inertial migration mechanism, we established a model with varying curvature ratios to study the effect of secondary flow on particle migration in the serpentine channel. This method used direct numerical simulation (DNS) to calculate inertial lift, mapped the inertial lift to cross sections of the serpentine channel, and deciphered the inertial migration by using the Lagrangian particle tracking (LPT) method. The inertial migration of microparticles is experimentally investigated to validate the established numerical model. The results indicate that particle migration in serpentine channels follows a two-stage migration. An increase in secondary flow accelerates the second stage of the migration process while slowing the first stage process. Subsequently, we investigated the effects of different parameters, including Reynolds number, aspect ratio, and blockage ratio, on the equilibrium positions of particles, providing guidelines for the high-resolution separation of particles. Taking flow resistance into account, the dimensionless study makes the separation of arbitrary-sized particles possible. This work reveals the migration mechanism in serpentine channels, paving the way for the inertial separation of the particles.

Identifiers

PMID39165174
PMCPMC11375625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.